Furthermore, results may encourage other research groups to use the M2 channel of influenza virus as therapeutic
target against the influenza A virus.
Not exact matches
Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to
target cells
against H1N1
influenza virus infection.
Their results, the researchers conclude, «show that computationally designed proteins have potent anti-viral efficacy in vivo and suggests promise for development of a new class of HA stem -
targeted antivirals for both therapeutic and prophylactic protection
against seasonal and emerging strains of
influenza.»
Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and less
Influenza vaccines that better
target the
influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and less
influenza surface protein called neuraminidase (NA) could offer broad protection
against various
influenza virus strains and less
influenza virus strains and lessen the...